SkinIO for Employers

Protect employees and your
bottom line through early
detection of skin cancer

Learn how SkinIO reduces high skin cancer claims

The challenge of skin cancer is not that there isn’t a cure; it is that we are not detecting skin cancer early enough.

Early detection saves lives and reduces costs

  • Skin cancer is the most common cancer in the US, more than all other cancer types combined.
  • Detected early, there is a 99% survival rate for skin cancer. With delayed detection, both mortality and treatment costs increase.
  • 1 in 5 Americans will develop skin cancer by the age of 70
Early Detection saves lives and costs

We make early detection, cost containment, and population health convenient by offering at-home and at-work AI-enabled skin screenings reviewed by board-certified dermatologists.

Solve for one of your top three health plan spends

  • Most organizations experience cancer as a top claim
  • Our convenient skin screening campaign is designed for high engagement and high impact
  • Both at-home and at-work options reach all employees
  • A perfect complement to any wellness program
  • Aggregated reporting demonstrates your program impact
Solve for one of your top three health plan claims

Our smart app guides work-from-home employees to provide screening access to all

  1. Employees are guided by the SkinIO app to capture images of their skin
  2. Outlier detection and mole-mapping technology is applied
  3. Board-certified dermatologists review images
  4. Results are communicated to employees
  5. Concerns are flagged for in-person follow-up and treatment
  6. Personalized digital skin records empower employees to monitor their skin from home
Preventive Health Engagement

Our technology is effective and secure

Our history of image processing to detect skin lesions gives us the experience to know how important quality photos are for dermatology

All photos are encrypted and stored in a secure, HIPAA-compliant cloud-based infrastructure

A Phase-1 clinical study with the Northwestern Department of Dermatology found our in-office mole-mapping technology to be highly effective in detecting new or changed lesions